+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis

Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis

Clinical and Vaccine Immunology 17(1): 68-72

One of the best-characterized tests for the diagnosis of neurocysticercosis is the enzyme-linked immunoelectrotransfer blot assay, developed at the CDC, which uses lentil lectin-purified glycoproteins (LLGPs) extracted from Taenia solium cysticerci. The purification of the LLGP antigens has been difficult to standardize, and the polyacrylamide gel system used for the immunoblot assay is not easily transferable to other laboratories. In this study, we developed a multiantigen printing immunoassay (MAPIA) to compare the performance of multiple recombinant Taenia solium proteins with the potential for the detection of cysticercosis and taeniasis. We prepared MAPIA strips using six cysticercosis and two taeniasis diagnostic proteins and compared the performance of the proteins with sera collected from defined cysticercosis and taeniasis cases. Of the six cysticercosis antigens, rT24H performed well in detecting cases with two or more viable cysts in the brain (sensitivity and specificity, 97% and 99.4%, respectively); the use of a combination of cysticercosis antigens did not improve the sensitivity of the test and decreased the specificity. None of the antigens could differentiate the different clinical presentations of cysticercosis. Both of the taeniasis antigens (rES33 and rES38) had the same sensitivity of 99.4% and specificities of 93.9% and 94.5%, respectively. Some cross-reactivity against rES33 and rES38 was found, especially with sera from cases infected with Schistosoma mansoni. We conclude that MAPIA is a simple and effective tool that may be used to compare antibody responses to different cysticercosis and taeniasis antigens and, in this case, may be useful for the rapid detection of T. solium cases.

(PDF emailed within 0-6 h: $19.90)

Accession: 035349681

Download citation: RISBibTeXText

PMID: 19906893

DOI: 10.1128/CVI.00339-09

Related references

Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurologica Scandinavica 111(2): 84-88, 2005

Prevalence of antibodies to unique Taenia solium oncosphere antigens in taeniasis and human and porcine cysticercosis. American Journal of Tropical Medicine and Hygiene 69(4): 438-444, 2003

Antigens and antibodies in sera from human cases of epilepsy or taeniasis from an area of Mexico where Taenia solium cysticercosis is endemic. Annals of Tropical Medicine and Parasitology 93(1): 69-74, 1999

Control of Taenia solium taeniasis and cysticercosis by focus-oriented chemotherapy of taeniasis. Southeast Asian Journal of Tropical Medicine and Public Health 22 Suppl: 284-286, 1991

PCR tools for the differential diagnosis of Taenia saginata and Taenia solium taeniasis/cysticercosis from different geographical locations. Diagnostic Microbiology & Infectious Disease 42(4): 243-249, April, 2002

Epidemiology of taeniasis/cysticercosis by Taenia solium and Taenia saginata. Ciencia Rural 30(3): 541-548, 2000

High prevalence of Taenia saginata taeniasis and status of Taenia solium cysticercosis in Bali, Indonesia, 2002-2004. Transactions of the Royal Society of Tropical Medicine and Hygiene 100(4): 346-353, 2005

Taeniasis and cysticercosis Taenia saginata, Taenia solium. Parasitic zooneses the editors Leon Jacobs et al: 348, 1982

Taeniasis and cysticercosis due to Taenia solium. Progress in Clinical Parasitology 4: 77-116, 1994

Taeniasis and cysticercosis due to Taenia solium. Salud Publica de Mexico 39(3): 225-231, 1997

Identification and purification of taeniasis diagnostic antigens from the tape worm Taenia solium in vitro cultures. Abstracts of the General Meeting of the American Society for Microbiology 102: 127, 2002

Cysticercosis vaccine cross protecting immunity with taenia solium antigens against experimental murine taenia crassiceps cysticercosis. Parasite Immunology (Oxford) 12(6): 687-696, 1990

Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis. Infection and Immunity 67(5): 2522-2530, 1999

Taeniasis and cysticercosis due to Taenia solium in Japan. Parasites and Vectors 5: 18, 2014